" class="no-js "lang="en-US"> CFO Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Woebot Health Names Matt Borowiecki Chief Financial Officer

Woebot Health, a mental health ally for people and businesses, today announced that it has […]

Gamida Cell Appoints Terry Coelho as CFO

Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, has announced […]

Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]

SynAct Pharma Appoints Björn Westberg as Chief Financial Officer (CFO)

SynAct Pharma has announced that Björn Westberg has been appointed Chief Financial Officer (CFO) and […]

Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel

Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]

Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer

Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]

Harbinger Health Appoints Vincent Lozada as Chief Financial Officer

Harbinger Health, a biotechnology company pioneering the detection of early cancer, announced today the appointment […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more